Abstract
Recently, it has been shown at both the cellular and behavioral levels that ethanol has effects on theN-methyl-d-aspartate (NMDA) and γ-aminobutyric acid (GABA)a receptor systems, leading to the possibility that the reinforcing effects of ethanol may be, at least partially, mediated via these receptor ionophores. In this study, a multiple schedule of ethanol and saccharin self-administration was used to study that possibility. Adult male Long-Evans rats were trained during 1-hr sessions to press on two different levers for 10% (w/v) ethanol and 0.1% (w/v) saccharin solutions, under an alternating 5-min, fixed-ratio-4 schedule of liquid availability. After training, tests were conducted with ethanol, NMDA antagonists and GABA agonists given before six consecutive sessions. Pretreatment with ethanol selectively decreased ethanol self-administration without altering saccharin self-administration. The competitive NMDA antagonist CPPene (d-3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid [SDZ EAA 494]) and the noncompetitive NMDA antagonist phencyclidine decreased both ethanol and saccharin self-administration. The GABA agonists pentobarbital and diazepam also failed to reduce ethanol self-administration, relative to saccharin. Although these results do not support the hypothesis that antagonism of the NMDA receptor system or activation of the GABA receptor system can selectively modify ethanol-reinforced responding, they identify important issues for designing the best strategies to be used to assess selective drug effects on ethanol self-administration.
Footnotes
-
Send reprint requests to: Robert L. Balster, Ph.D., Department of Pharmacology/Toxicology, Medical College of Virginia/VCU, Box 980310, Richmond, VA 23298-0310.
-
↵1 This research was supported by National Institute on Alcoholism and Alcohol Abuse Grant AA08437 and National Institute on Drug Abuse Grant DA01442.
-
↵2 Supported by National Institutes of Health Training Fellowship AA05357.
-
↵3 Present address: Department of Psychiatry and Behavioral Sciences, M.S.I., University of Texas Health Science Center at Houston, 1300 Moursund, Houston, TX 77030.
- Abbreviations:
- AP-5
- 2-amino-5-phosphonopentanoic acid
- AP-7
- 2-amino-7-phosphonoheptanoic acid
- CPPene
- d-3-(2-carboxypiperazine-4-yl)-1-propenyl-1-[phosphonic acid [SDZ EAA 494]
- FR
- fixed ratio
- GABA
- γ-aminobutyric acid
- NMDA
- N-methyl-d-aspartate
- PCP
- phencyclidine
- Received June 25, 1996.
- Accepted November 19, 1996.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|